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CLINICAL STUDIES
A Structured Clinical Model for Predicting the
Probability of Pulmonary Embolism
Massimo Miniati, MD, PhD, Simonetta Monti, MD, PhD, Matteo Bottai, ScD
PURPOSE: To develop a structured model to predict the clin-
ical probability of pulmonary embolism.
METHODS: We studied 1100 consecutive patients with sus-
pected pulmonary embolism in whom a definite diagnosis had
been established. We used logistic regression analysis to esti-
mate the probability of pulmonary embolism based on patients’
clinical characteristics; the probability was categorized as low
(10%), intermediate (10%, 50%), moderately high
(50%,90%), or high (90%).
RESULTS: The overall prevalence of pulmonary embolism was
40% (n  440). Ten characteristics were associated with an
increased risk of pulmonary embolism (male sex, older age,
history of thrombophlebitis, sudden-onset dyspnea, chest pain,
hemoptysis, electrocardiographic signs of acute right ventricu-
lar overload, radiographic signs of oligemia, amputation of the
hilar artery, and pulmonary consolidation suggestive of infarc-
tion), and five were associated with a decreased risk (prior car-
diovascular or pulmonary disease, high fever, pulmonary con-
solidation other than infarction, and pulmonary edema on the
chest radiograph). With this model, 432 patients (39%) were
rated a low probability, of whom 19 (4%) had pulmonary em-
bolism; 283 (26%) were rated an intermediate probability, of
whom 62 (22%) had pulmonary embolism; 72 (7%) were rated
a moderately high probability, of whom 53 (74%) had pulmo-
nary embolism; and 313 (28%) were rated a high probability, of
whom 306 (98%) had pulmonary embolism.
CONCLUSION: This prediction model may be useful for esti-
mating the probability of pulmonary embolism before obtain-
ing definitive test results. Am J Med. 2003;114:173–179. ©2003
by Excerpta Medica Inc.
The clinical diagnosis of pulmonary embolism isdeemed unreliable because the signs, symptoms,and laboratory data are often nonspecific (1).
However, certain clinical findings, such as unexplained
dyspnea or chest pain, raise the suspicion of pulmonary
embolism and may be useful in selecting patients for fur-
ther diagnostic testing (2,3). Furthermore, the results of
three prospective studies (4 – 6) have indicated that phy-
sicians’ estimates of the clinical likelihood of pulmonary
embolism, even if based on empirical assessment, do have
predictive value, and that the clinical probability of pul-
monary embolism can be used as pretest probability be-
fore objective testing.
Several attempts have been made to develop prediction
models for pulmonary embolism (7–9). We previously
described a clinical diagnostic algorithm based on the
presence of one or more of three relevant symptoms
(sudden-onset dyspnea, chest pain, or fainting) in asso-
ciation with one of four abnormalities (electrocardio-
graphic [ECG] signs of right ventricular overload, radio-
graphic signs of oligemia, amputation of the hilar artery,
or pulmonary consolidation suggestive of infarction). In
comparison with pulmonary angiography, this algorithm
had a sensitivity of 84% and a specificity of 95% (8).
In the present study, we used logistic regression models
to identify parameters significantly associated with pul-
monary embolism in 1100 consecutive patients admitted
to our institution with clinically suspected pulmonary
embolism. In most patients, pulmonary angiography was
used as the reference diagnostic standard.
METHODS
Sample
The sample consisted of 1100 consecutive patients who
were referred to our institution for suspected pulmonary
embolism between November 1, 1991, and December 31,
1999, and in whom the disease was diagnosed or ex-
cluded. The clinical characteristics of 500 of these patients
have been described (8). All patients were examined ac-
cording to a standardized protocol that included clinical
evaluation, perfusion lung scanning, and pulmonary an-
giography (5,8).
Clinical Evaluation
Upon study entry, patients were examined by one of 12
on-call pulmonary physicians, all of whom had experi-
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ence with the diagnostic procedures for pulmonary em-
bolism. The clinical evaluation included a detailed clini-
cal history, physical examination, interpretation of the
ECG and the chest radiograph, and measurement of the
partial pressures of oxygen (PaO2) and carbon dioxide
(PaCO2) in arterial blood. All clinical and laboratory data
were recorded by the physician on a standard form before
any further objective testing.
Immobilization was defined as strict bed rest for more
than 3 consecutive days within the previous 4 weeks. His-
tory of thrombophlebitis required a documented episode
treated with anticoagulant therapy. Major surgical proce-
dures and radiologically confirmed fractures of the lower
extremity within the previous 4 weeks were noted. Estro-
gen use was defined as use of estrogen-containing drugs
within the previous 3 months. The postpartum period
was defined as pregnancy within the previous 3 months.
Ischemic heart disease was considered to be present if a
patient had typical angina on exertion, used antianginal
medication, or had a prior myocardial infarction docu-
mented by ECG or cardiac enzyme elevation. Hyperten-
sion was diagnosed if there was documented persistent
elevation of arterial pressure (systolic 160 mm Hg or
diastolic95 mm Hg) or if the patient was receiving an-
tihypertensive medication. Cerebrovascular disorders in-
cluded prior transient ischemic attack or stroke. Valvular
disease was recorded if there was hemodynamic or echo-
cardiographic evidence of mitral or aortic stenosis or re-
gurgitation. Chronic obstructive pulmonary disease was
recorded if there was evidence of fixed airflow obstruc-
tion, chronic mucous hypersecretion, or emphysema.
Cancer was recorded if there was evidence of clinically
active disease with pathologic diagnosis within the previ-
ous 3 months. Diabetes mellitus was diagnosed if the pa-
tient was on long-term therapy with insulin or oral hypo-
glycemic drugs. Thyroid dysfunction requiring treatment
was noted.
In evaluating dyspnea, attention was paid to establish
whether it was sudden or gradual in onset, and whether it
was associated with orthopnea. Chest pain was catego-
rized as pleuritic or substernal. Unilateral leg swelling
with tenderness and redness of the skin were regarded as
a sign suggestive of deep vein thrombosis.
Arterial blood samples were obtained upon study entry
in all patients while they were breathing room air. Elec-
trocardiograms obtained within 24 hours before study
entry were evaluated by the on-call physician. The follow-
ing abnormalities, if new, were regarded as suggestive of
right ventricular overload: S wave in lead I and Q wave in
lead III, each of amplitude 1.5 mm, with or without
T-wave inversion in lead III (S1Q3T3 or S1Q3); S waves in
leads I, II, and III, each of amplitude1.5 mm (S1S2S3);
T-wave inversion in right precordial leads; transient right
bundle branch block; and pseudoinfarction (10).
Chest radiographs were obtained in all patients at the
time of study entry using a stationary X-ray unit. In most
patients, posteroanterior and lateral views were taken in
the upright or seated position. For patients who were un-
able to stand or sit (30% in our study), anteroposterior
chest radiographs were obtained in the supine or semire-
cumbent position. Chest radiographs were examined by
the physician according to a standard form that included
the following items: size and shape of the heart and hilar
arteries, position of the diaphragm, presence or absence
of pulmonary parenchymal abnormalities (e.g., consoli-
dation, atelectasis, oligemia, edema), and pleural effu-
sion. When evaluating the hilar arteries, attention was
paid to the presence of abrupt vascular amputation that
gave the hilum a “plump” appearance (11,12). In retro-
spective studies, this radiographic abnormality has been
strongly associated with pulmonary embolism (13,14).
Pulmonary consolidation was considered suggestive of
infarction if it had a semicircular or half-spindle shape
and was arranged peripherally along the pleural surface
(so-called Hampton’s hump) (15,16). Oligemia was con-
sidered to be present if, in a given lung region, the pul-
monary vasculature was greatly diminished with con-
comitant hyperlucency of the lung parenchyma (17).
Criteria for Diagnosing or Excluding Pulmonary
Embolism
Diagnosis was based on angiographic or autopsy docu-
mentation of pulmonary embolism. Exclusion criteria
were a normal pulmonary angiogram, absence of pulmo-
nary emboli at autopsy, or a normal or near-normal per-
fusion scan. Performing pulmonary angiography in pa-
tients with normal or near-normal scans was deemed un-
ethical because available data indicate that such a
scintigraphic pattern, in itself, makes the diagnosis very
unlikely (4,18 –20). Six-month clinical follow-up was ob-
tained in patients with normal or near-normal scans.
Statistical Analysis
The univariate relations between baseline characteristics
and the diagnosis of pulmonary embolism were assessed
with the Fisher exact test or the Wilcoxon rank sum test.
Two-sided P values 0.05 were considered statistically
significant.
To estimate the probability of pulmonary embolism,
we developed a logistic regression model that initially in-
cluded all demographic, clinical, and laboratory data.
Continuous variables were split into tertiles. A stepwise
procedure was used, and variables with a P value 0.20
were removed from the model. Remaining variables were
examined individually and kept in the model if they were
statistically significant or appeared to be confounders,
defined as variables whose removal changed another vari-
able’s coefficient by 10%. Next, all variables that had
been removed were reintroduced one at a time and kept
in the model if they were statistically significant or con-
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founders. Finally, all pairwise interactions were tested;
none were statistically significant.
The area under the receiver operating characteristic
(ROC) curve of the final model was calculated. To esti-
mate 95% confidence intervals, 1000 bootstrap samples
were generated, each of which consisted of 1100 observa-
tions selected randomly with replacement from the orig-
inal data. The area under the ROC curve was calculated
for each bootstrap sample, and the 95% confidence inter-
val was obtained as the 5th and 95th percentiles of the
1000 bootstrap values (21).
The logistic regression model was cross-validated to
check for overfitting of the data according to the follow-
ing steps: step 1, the data set was split randomly into 10
equal subsamples; step 2, regression coefficients were es-
timated for nine subsets (training set); step 3, the predic-
tion equation was applied to the remaining subset (vali-
dation set) and the area under the ROC curve was calcu-
lated; step 4, steps 2 and 3 were repeated for each subset in
turn. The 10 areas under the ROC curves were compared
with those obtained on the same 10 validation sets by
using the original prediction equation developed from
the whole study sample.
RESULTS
The 1100 patients had a median age of 68 years (range, 15
to 94 years); 498 (45%) of them were male (Table 1).
Eighty-one percent (n  891) were hospitalized at the
time of study entry. The median time between onset of
symptoms and study entry was 1 day (range, 0 to 30 days).
Based on angiography and autopsy data, the prevalence
of pulmonary embolism was 40% (n 440). Among pa-
tients without pulmonary embolism, 242 had the diagno-
sis excluded based on a normal or near-normal perfusion
scan. None of these patients had symptomatic venous
thromboembolism during a 6-month follow-up.
Patients with confirmed pulmonary embolism did not
differ in age and sex from those without pulmonary em-
bolism. The median PaO2 was 63 mm Hg (range, 31 to 108
mm Hg) in patients with pulmonary embolism and 66
mm Hg (range, 30 to 129 mm Hg) in those without (P
0.03). The median PaCO2 was 33 mm Hg (range, 20 to 49
mm Hg) in patients with pulmonary embolism and 34
mm Hg (range, 14 to 65 mm Hg) in those without (P
0.02).
Multivariate Predictors of Pulmonary Embolism
Ten characteristics were associated with an increased
likelihood of pulmonary embolism: male sex, older age,
history of thrombophlebitis, sudden-onset dyspnea,
chest pain, hemoptysis, ECG signs of acute right ventric-
ular overload, radiographic signs of oligemia, amputa-
tion of the hilar artery, and pulmonary consolidation
suggestive of infarction (Table 2). Variables associated
with a decreased likelihood of pulmonary embolism in-
cluded prior cardiovascular or pulmonary disease, high
fever, pulmonary consolidation other than infarction,
and pulmonary edema on the chest radiograph. The area
under the ROC curve for the logistic regression model
was 0.95 (95% confidence interval: 0.93 to 0.96).
Assessing the Clinical Probability of Pulmonary
Embolism
The probability of pulmonary embolism in a given pa-
tient— based on the characteristics of that patient that are
listed in Table 2— can be derived from the formula in
Table 2, or by using the Figure, which displays the relation
between the sum of the regression coefficients and the
predicted probability of pulmonary embolism. There was
a very close agreement between the probability of pulmo-
nary embolism predicted by the model and the actual
prevalence (Figure).
When the probability of pulmonary embolism was di-
vided into four categories: low (10%), intermediate
(10%, 50%), moderately high (50%, 90%), and
high (90%), the actual prevalence of pulmonary embo-
lism among patients in each of the categories was consis-
tent with the predicted risks (Table 3).
Cross-Validation
The models developed from the training sets all included
the same covariates as the final model, except for one
model that did not include pulmonary edema. The pre-
diction equations developed from the 10 training sets,
when applied to the 10 validation sets, yielded areas un-
der the ROC curve that averaged 0.94 (range, 0.90 to
0.97). In the same validation sets, the prediction equation
developed from the whole study sample yielded areas un-
der the ROC curve that averaged 0.95 (range, 0.91 to
0.98).
DISCUSSION
The results of large-scale prospective studies of the diag-
nosis of pulmonary embolism lend support to the con-
cept that clinical assessment is a fundamental step in the
diagnostic work-up of patients (4 – 6). Although the di-
agnostic yield of individual signs, symptoms, and com-
mon laboratory tests is limited, the combination of these
variables, either by empirical assessment or by a predic-
tion rule, can be used to express the clinical probability of
pulmonary embolism.
In a multicenter Canadian study (7), the clinical prob-
ability of pulmonary embolism was categorized as low,
moderate, or high based on the presenting signs and
symptoms, interpretation of the ECG and chest radio-
graph, measurement of arterial oxygen saturation, pres-
ence or absence of an alternative diagnosis, and identifi-
cation of predisposing risk factors for venous thrombo-
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(n 660) P Value
Number (%)
Male sex 205 (47) 293 (44) 0.50
Age (years) 0.19
15–62 153 (35) 240 (36)
63–72 127 (29) 214 (32)
73–94 160 (36) 206 (31)
Pre-existing disease or condition
Cardiovascular 128 (29) 273 (41) 0.0001
Pulmonary 37 (8) 132 (20) 0.0001
Neoplastic 70 (16) 92 (14) 0.39
Endocrine 35 (8) 82 (12) 0.02
Risk factors
Immobilization 242 (55) 290 (44) 0.0001
Surgery 160 (36) 224 (34) 0.44
Thrombophlebitis (ever) 153 (35) 109 (17) 0.0001
Bone fractures (lower limb) 78 (18) 86 (13) 0.04
Estrogen use 4 (1) 6 (1) 1.00
Pregnancy or postpartum 2 (0.5) 10 (2) 0.14
Symptoms
Dyspnea (sudden-onset) 358 (81) 210 (32) 0.0001
Dyspnea (gradual-onset) 14 (3) 143 (22) 0.0001
Orthopnea 3 (1) 62 (9) 0.0001
Chest pain 248 (56) 232 (35) 0.0001
Fainting 114 (26) 83 (13) 0.0001
Hemoptysis 31 (7) 25 (4) 0.02
Signs
Tachycardia (100 beats per
minute)
124 (28) 180 (27) 0.78
Leg swelling (unilateral) 101 (23) 63 (10) 0.0001
Fever38°C 28 (6) 140 (21) 0.0001
Wheezes 11 (3) 75 (11) 0.0001
Arterial blood gases
PaO2 (mm Hg) 0.03
30–59 167 (38) 204 (31)
60–70 145 (33) 222 (34)
71–129 128 (29) 234 (35)
PaCO2 (mm Hg) 0.02
14–31 161 (36) 226 (34)
32–35 162 (37) 207 (31)
36–65 117 (27) 227 (34)
ECG signs of acute right ventricular
overload
200 (45) 54 (8) 0.0001
Chest radiograph
Right heart enlargement 141 (32) 68 (10) 0.0001
Oligemia 196 (45) 6 (1) 0.0001
Amputation of hilar artery 149 (34) 4 (1) 0.0001
Consolidation (infarction) 74 (17) 3 (0.5) 0.0001
Consolidation (no infarction) 17 (4) 127 (19) 0.0001
Plate-like atelectasis 123 (28) 141 (21) 0.01
Elevated diaphragm (unilateral) 185 (42) 206 (31) 0.0001
Pleural effusion 198 (45) 230 (35) 0.001
Pulmonary edema 1 (0.2) 71 (11) 0.0001
ECG electrocardiogram; PaCO2 partial pressure of carbon dioxide (arterial); PaO2 partial pressure of oxygen (arterial).
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embolism. In that study (7), the clinical probability was
low in 59% of the patients, of whom 3% had pulmonary
embolism; moderate in 33% (28% with pulmonary em-
bolism); and high in 8% (78% with pulmonary embo-
lism). Because so few patients were categorized as high
risk, that model seems more useful for ruling out—rather
Table 2. Factors Independently Associated with Pulmonary Embolism*
Factor Regression Coefficient
Odds Ratio
(95% Confidence Interval) P Value
Male sex 0.81 2.3 (1.4–3.6) 0.001
Age (years)
63–72 0.59 1.8 (1.0–3.1) 0.04
73 0.92 2.5 (1.4–4.6) 0.002
Pre-existing disease
Cardiovascular 0.56 0.6 (0.4–0.9) 0.03
Pulmonary 0.97 0.4 (0.2–0.7) 0.005
Thrombophlebitis (ever) 0.69 2.0 (1.2–3.3) 0.007
Symptoms
Dyspnea (sudden-onset) 1.29 3.6 (2.3–5.7) 0.0001
Chest pain 0.64 1.9 (1.2–3.0) 0.004
Hemoptysis 0.89 2.4 (1.0–6.0) 0.06
Fever38°C 1.17 0.3 (0.2–0.7) 0.002
ECG signs of acute right ventricular overload 1.53 4.6 (2.7–7.8) 0.0001
Chest radiograph
Oligemia 3.86 47 (19–119) 0.0001
Amputation of hilar artery 3.92 51 (17–152) 0.0001
Consolidation (infarction) 3.55 35 (9.7–126) 0.0001
Consolidation (no infarction) 1.23 0.3 (0.1–0.6) 0.001
Pulmonary edema 2.83 0.1 (0.0–0.6) 0.02
Constant 3.26
* To estimate the probability of pulmonary embolism, add all of the regression coefficients that apply to a particular patient to the constant (3.26).
The probability of pulmonary embolism then equals 1 (1 exp ( sum)). For example, a 50-year-old woman with a history of thrombophlebitis
(0.69), sudden-onset dyspnea (1.29), and amputation of a hilar artery on chest radiograph (3.92), but no other characteristics, would have a sum of
0.69 1.29 3.92 3.26, or 2.64. Her probability of pulmonary embolism is 1 (1 exp(2.64)) 93.3%.
ECG electrocardiogram.
Figure. Probability of pulmonary embolism, as predicted by the model (smooth curve), and the actual prevalence of pulmonary
embolism, as observed in the sample (step curve), for different sums of coefficients. See Table 2 for instructions on how to calculate
the sum of the coefficients.
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than ruling in—the diagnosis. The prevalence of pulmo-
nary embolism in that study was only 17%, much lower
than in other prospective studies (4 – 6), and only 4% of
the patients had confirmation or exclusion of pulmonary
embolism based on pulmonary angiography. Moreover,
the model relies on the clinician’s subjective judgement as
to whether an alternative diagnosis is as or more likely,
and is therefore difficult to standardize.
Recently, a simple clinical score was developed to strat-
ify outpatients in an emergency department with sus-
pected pulmonary embolism into groups of low, inter-
mediate, or high probability (9). In that study, the prev-
alence of pulmonary embolism was 27%, and only a
minority of patients underwent pulmonary angiography
for a definitive diagnosis. In a multivariate analysis, eight
factors were associated with pulmonary embolism: recent
surgery, previous thromboembolic event, older age, hy-
pocapnia, hypoxemia, tachycardia, band atelectasis, or el-
evated diaphragm on the chest radiograph. The score is
calculated by assigning points based on these character-
istics. A score4 was considered low probability (49% of
all patients of whom 10% had pulmonary embolism); a
score of 5 to 8 was considered intermediate probability
(44% of all patients of whom 38% had pulmonary embo-
lism); and a score 9 was considered high probability
(6% of all patients of whom 81% had pulmonary embo-
lism) (9). Although the score is based only on standard-
ized criteria, very few patients were high risk. In addition,
the model was based on patients in an emergency depart-
ment and may not be valid in assessing the clinical prob-
ability of pulmonary embolism in hospitalized patients.
In contrast, most (80%) of our patients were hospi-
talized at the time of study entry. A substantial propor-
tion had cardiovascular or pulmonary disorders that may
mimic the clinical presentation of pulmonary embolism;
about 50% suffered from prolonged immobilization,
about 40% had recent surgery, and 15% had recent
trauma. In addition, the prevalence of pulmonary embo-
lism (40%) was substantially higher than in the previous
two studies (7,9). In terms of predictive accuracy, the
logistic regression model that we developed yields better
results than those reported previously (7,9). The area un-
der the ROC curve of our model was 0.95 using the orig-
inal prediction equation, and 0.94 after cross-validation,
compared with 0.79 (0.77 after cross-validation) in one of
the previous studies (9).
Instead of using a point-scale score that is proportional
to the regression coefficients, we estimated the probabil-
ity of pulmonary embolism directly from the sum of the
regression coefficients. Although calculation of the prob-
ability of pulmonary embolism by hand is complex, the
Figure can be used as a graphical tool. The score can also
be incorporated into electronic devices that would enable
physicians to use the estimated probability of pulmonary
embolism as the pretest probability when calculating the
post-test probability after whichever objective testing
they consider most appropriate in their own clinical set-
ting. As an example, Table 4 shows the relation between
the pretest and post-test probability of pulmonary embo-
lism conditioned by lung scan results. Post-test probabil-
ity was calculated by means of Bayes’ theorem using sen-
sitivity and specificity values for ventilation-perfusion
Table 3. Comparison between Probability Estimates and Ac-











10% 432 (39) 19 4 (3–7)
10% to50% 283 (26) 62 22 (17–27)
50% to90% 72 (7) 53 74 (62–83)
90% 313 (28) 306 98 (95–99)

















Post-test Probability of Pulmonary Embolism (%)
10% 0–60 0–8 0–3 0–58 0–2
10% to50% 61–93 9–43 3–22 59–92 2–13
50% to90% 93–99 44–87 22–71 93–99 14–58
90% 99–100 88–100 72–100 99–100 59–100
* Based on data from reference 4. High-probability scan: segmental or greater perfusion defects with normal ventilation; intermediate-probability
scan: not falling into high or low probability; low-probability scan: matched V-Q defects.
† Based on data from reference 5. Scan suggestive of pulmonary embolism: one or more wedge-shaped perfusion defects; scan not suggestive of
pulmonary embolism: one or more perfusion defects other than wedge shaped.
V-Q ventilation-perfusion.
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(V-Q) and for perfusion scan (without ventilation imag-
ing), as reported in two broad prospective studies (4,5).
Results of this analysis indicate that a high-probability
V-Q scan, or a perfusion scan suggestive of pulmonary
embolism, associated with a pretest probability 50%
make the diagnosis of pulmonary embolism very likely
and justify the institution of anticoagulant therapy. By
contrast, a low-probability V-Q scan, or a perfusion scan
not suggestive of pulmonary embolism, paired with a low
(10%) pretest probability make the diagnosis of pul-
monary embolism very unlikely and justify withholding
of anticoagulant therapy. An intermediate-probability
V-Q scan does not modify the pretest probability of pul-
monary embolism and should be regarded as nondiag-
nostic. Finally, when the pretest probability and lung scan
results are discordant, the post-test probability is neither
sufficiently high nor sufficiently low to permit therapeu-
tic decisions; under these circumstances, further diagnos-
tic testing, such as pulmonary angiography or spiral com-
puterized tomographic angiography, are indicated.
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